GLP-1 medications slow gastric emptying and affect appetite-regulating hormones, which can trigger nausea as a side effect
There are concerns that drug could retrigger a restrictive eating disorder in someone diagnosed with one previously, or even trigger one in someone who hadnt had one before
Huisamen, B., Genis, A., Marais, E
It is currently conducting trials that could ultimately lead to its use in concert with GLP-1 drugs (a process known as adjunctive therapy) so patients dont lose lean muscle
Since the FDA does not regulate supplements, independent verification is essential for safety, accuracy, and consumer trust
Likewise, once a week administration of efpeglenatide, a long acting GLP-1RA, significantly reduced the body weight in obese patients (172)